Corbus Pharmaceuticals (CRBP) PT Raised to $57 at Oppenheimer
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $10.37 +2.78%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Jeff Jones raised the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $57.00 (from $53.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
